Fidelity Investments
CPIX icon

Fidelity Investments’s Cumberland Pharmaceuticals CPIX Stock Holding History

Fidelity Investments’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-422
Closed -$1K – 4421
2021
Q2 		$1K Hold
422
– – ﹤0.01% 4012
2021
Q1 		$1K Hold
422
– – ﹤0.01% 3815
2020
Q4 		$1K Hold
422
– – ﹤0.01% 3668
2020
Q3 		$1K Hold
422
– – ﹤0.01% 3539
2020
Q2 		$1K Buy
+422
New +$1.53K ﹤0.01% 3442

Other funds holding CPIX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFP
Sterling Financial Planning Sparta, New Jersey $337M AUM 19.27% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments's CPIX Position: Q3 2021 in Review

Fidelity Investments sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2021, closing a stake of 422 shares — an estimated $1K sold.

Fidelity Investments first reported a position in CPIX in Q2 2020 and held it in 5 quarters. The position peaked at $1K in Q2 2021. 23 funds tracked by Wall St. Rank hold CPIX as of Q3 2021.

  • Fidelity Investments reported no remaining Cumberland Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Fidelity Investments sold 422 Cumberland Pharmaceuticals shares in Q3 2021, an estimated $1K.
  • Fidelity Investments first reported a position in Cumberland Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Fidelity Investments's Cumberland Pharmaceuticals position peaked at $1K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2021.

Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.